COSTA MESA, Calif.--(BUSINESS WIRE)--Oxygen Biotherapeutics, Inc. (OTCBB:OXBO) announced today that company Chairman and CEO, Chris Stern, has posted a new entry on his blog on the company website. The latest blog amplifies on the company’s plans for interacting with the FDA and discusses further development plans for Oxycyte. He also discusses his change in status to an employee of the company as detailed in the Form 8-K filed today.
